Pluri (PLUR) EPS (Weighted Average and Diluted) (2021 - 2025)
Pluri (PLUR) reported EPS (Weighted Average and Diluted) of -$0.71 for Q4 2025, down 33.96% year-over-year from -$1.08 in Q4 2024, and down 9.23% quarter-over-quarter from -$0.65 in Q3 2025.
Pluri (PLUR) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Pluri (PLUR) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.71 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.71, down 33.96% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.3 (up 10.57% YoY), and the FY2025 annual result was -$3.56, up 10.78% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$0.71 in Q4 2025 per PLUR's latest filing, from -$0.65 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $1.76 in Q1 2023 and troughed at -$1.08 in Q3 2024.
- A 5-year average of -$0.41 and a median of -$0.59 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 642.77% in 2023 and fell as far as 358.04% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.34 in 2021, then surged by 38.36% to -$0.21 in 2022, then sank by 358.04% to -$0.96 in 2023, then soared by 44.79% to -$0.53 in 2024, then sank by 33.96% to -$0.71 in 2025.
- Business Quant data shows PLUR's EPS (Weighted Average and Diluted) at -$0.71 in Q4 2025, -$0.65 in Q3 2025, and -$1.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Pluri | 21.85 Mn | 22.34 Mn | 86,000.00 | -0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.71 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -0.94 |
| Dec 31, 2024 | -0.53 |
| Sep 30, 2024 | -1.08 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -0.96 |
| Sep 30, 2023 | -0.96 |
| Jun 30, 2023 | 1.44 |
| Mar 31, 2023 | 1.76 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | -0.22 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.36 |